ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas V. Bilfinger
Irvin B. Krukenkamp
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilfinger, T. V.
Right arrow Articles by Stefano, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilfinger, T. V.
Right arrow Articles by Stefano, G. B.

Ann Thorac Surg 2000;69:1183-1187
© 2000 The Society of Thoracic Surgeons


ORIGINAL ARTICLES: CARDIOVASCULAR

Functional assessment of disease-free saphenous vein grafts at redo coronary artery bypass grafting

Thomas V. Bilfinger, MDa, James A. Vosswinkel, MDa, Christos M. Rialas, MSa, Irvin B. Krukenkamp, MDa, George B. Stefano, PhDa

a Division of Cardiothoracic Surgery, Department of Surgery, University Hospital and Medical Center, State University of New York at Stony Brook, Stony Brook, New York, USA

Address reprint requests to Dr Bilfinger, Division of Cardiothoracic Surgery, Department of Surgery, HSC T-19 080, University Hospital and Medical Center, Stony Brook, NY 11794-8191
e-mail: bifinge{at}surg.som.sunysb.edu

Background. Reoperations for coronary artery bypass grafting are on the rise. The general rule of replacing all saphenous vein grafts (SVGs) older than 5 years of age at the time of reoperation has recently been challenged on clinical grounds. This study provides functional data of endothelial behavior in long-term vein grafts.

Methods. Previously placed SVGs were removed at the time of redo operations. Nitric oxide (NO) measurements in real time were carried out before and after stimulation with morphine. The measurements were compared to the angiographic appearance of the grafts obtained prior to operation. Grafts were categorized into 3 groups: disease-free, moderately diseased, and severely diseased.

Results. Sixteen grafts were analyzed. Five were angiographically disease-free, 4 had moderate, and 7 severe disease. In the disease-free group, peak NO production after 10-6 mol/L morphine stimulation was 35 mol/L, equivalent to the production of native saphenous vein. The severely diseased group did not demonstrate an increase in NO production, and the moderately diseased group produced a small rise in production.

Conclusions. Measurement of NO release of old SVGs, when angiographically pristine, equals that of native saphenous vein. These findings support the recent clinical observations that long-term angiographically disease-free vein grafts are biologically privileged.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Tatoulis, B. F. Buxton, and J. A. Fuller
The radial artery in coronary re-operations
Eur. J. Cardiothorac. Surg., March 1, 2001; 19(3): 266 - 273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.